MRNA
Moderna, Inc.
NASDAQ · Healthcare · Biotechnology · US
$145.55
−2.23%Margins
Gross margin
-12.6%
EBITDA margin
-127.0%
EBIT margin
-149.0%
Net margin
-141.4%
FCF margin
-54.9%
-46.6%
Return on equity
-28.7%
Return on assets
-41.3%
Return on invested capital
0.20x
Asset turnover
-$1.1B
Cash from operations
$13
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026